TRANSCEND CAPITAL ADVISORS, LLC: XYLD position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of TRANSCEND CAPITAL ADVISORS, LLC on XYLD, newest first. How the timeline and the estimate are built.
TRANSCEND CAPITAL ADVISORS, LLC held 12,181 XYLD shares at 2026-06-30 per its 13F-HR filed 2026-08-04.
the latest 13F is the newest step
- period ended2026-06-3013F 12,181 sharesChange vs previous 13F +2,627 shares
0.03% of the 13F portfolio, value $496,844.
13F-HR 0001776082-26-000004 filed by TRANSCEND CAPITAL ADVISORS, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 9,554 sharesChange vs previous 13F +679 shares
0.03% of the 13F portfolio, value $373,861.
13F-HR 0001776082-26-000003 filed by TRANSCEND CAPITAL ADVISORS, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 8,875 sharesChange vs previous 13F +1,461 shares
0.03% of the 13F portfolio, value $360,572.
13F-HR 0001776082-26-000001 filed by TRANSCEND CAPITAL ADVISORS, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 7,414 sharesChange vs previous 13F +1,159 shares
0.02% of the 13F portfolio, value $291,058.
13F-HR 0001776082-25-000008 filed by TRANSCEND CAPITAL ADVISORS, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 6,255 sharesChange vs previous 13F not available
0.02% of the 13F portfolio, value $243,580.
13F-HR 0001776082-25-000004 filed by TRANSCEND CAPITAL ADVISORS, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).